Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janssen
Janssen
Janssen Recruiting for Phase III Trials of Potential Myasthenia Gravis Game Changer
BioSpace
Mon, 06/20/22 - 10:57 am
Janssen
JNJ
clinical trials
nipocalimab
myasthenia gravis
Janssen's Imbruvica Demonstrates Significant Survival Outcomes In Older Lymphoma Patients
BioSpace
Mon, 06/6/22 - 10:03 am
ASCO 2022
JNJ
Janssen
Imbruvica
clinical trials
lymphoma
ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it
Fierce Pharma
Fri, 05/27/22 - 10:19 am
ASCO 2022
JNJ
Janssen
pan-tumor
Balversa
Janssen Presents New Data that could Set Anti-Inflammatory Drug Apart
BioSpace
Thu, 05/19/22 - 09:00 pm
JNJ
Janssen
Tremfya
Skyrizi
AbbVie
anti-inflammatories
J&J ends hepatitis B and HPV portions of Bavarian Nordic collab
Endpoints
Mon, 05/9/22 - 10:33 am
JNJ
Janssen
Bavarian Nordic
vaccines
hepatitis B
HPV
Illumina secures drug discovery tie-ups with Janssen, Deerfield
Biopharma Reporter
Mon, 05/9/22 - 10:11 am
Illumina
Janssen
JNJ
Deerfield Management
drug discovery
J&J new social media series supports and celebrates ‘warrior’ nurses in pulmonary hypertension
Endpoints
Sun, 05/8/22 - 12:21 pm
JNJ
Janssen
pulmonary hypertension
social media
nurses
With millions on the line, Alkermes, J&J start arbitration over drug delivery tech dispute
Fierce Pharma
Fri, 04/22/22 - 10:32 am
Alkermes
JNJ
Janssen
drug delivery
Nanocrystal
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T
BioSpace
Thu, 04/21/22 - 10:57 am
Legend Biotech
Janssen
Carvykti
cilta-cel
CAR-T
With competitors circling, ViiV wins another label update for long-acting HIV injectable Cabenuva
Endpoints
Thu, 03/24/22 - 08:33 pm
ViiV Healthcare
GSK
FDA
Cabenuva
HIV
Janssen
J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data
Fierce Pharma
Mon, 02/21/22 - 10:37 am
JNJ
Janssen
Tremfya
Crohn's Disease
Remix Therapeutics signs Janssen licensing deal that could top $1B
Fierce Biotech
Thu, 02/17/22 - 10:53 am
Remix Therapeutics
RNA
Janssen
JNJ
small molecule drugs
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
Tue, 02/15/22 - 10:32 am
AC Immune
Janssen
JNJ
vaccines
Alzheimer's disease
clinical trials
J&J's Blue Jacket Fashion Show returns live to boost prostate cancer awareness
Fierce Pharma
Tue, 02/15/22 - 10:29 am
pharma marketing
JNJ
Janssen
oncology
prostate cancer
J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets
Fierce Biotech
Thu, 02/3/22 - 11:18 am
JNJ
Janssen
Mersana
antibody-drug conjugate
biobucks
J&J goes after another FDA approval for a cancer bispecific
Pharmaforum
Thu, 12/30/21 - 10:53 am
JNJ
bispecific antibodies
cancer
FDA
Janssen
teclistamab
Multiple Myeloma
AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance 'digital' endpoint for atopic dermatitis
Endpoints
Tue, 11/2/21 - 10:48 am
atopic dermatitis
eczema
nocturnal scratch
digital endpoint
AbbVie
Janssen
JNJ
Novartis
Pfizer
UCB Pharma
digital pharma
Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab
BioSpace
Thu, 10/21/21 - 09:24 am
F-star Therapeutics
Janssen
FS120
ESMO
clinical trials
Janssen, Brickell and ViiV are Knocking on FDA's Door
BioSpace
Sat, 10/9/21 - 10:56 pm
FDA
Janssen
Stelara
juvenile psoriatic arthritis
Brickell Bio
sofpironium bromide gel
ViiV Healthcare
HIV
Triumeq
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
FDA
drug approvals
Bayer
Kerendia
Astellas
Padcev
Teva Pharmaceutical
ArmonAir RespiClick
Janssen
Darzalex Faspro
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »